A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
- Status
- TERMINATED
- Phase
- PHASE2
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE4
A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- NA
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
- Status
- COMPLETED
- Phase
- PHASE4
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg
- Status
- COMPLETED
- Phase
- PHASE1
Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)
- Status
- COMPLETED
- Phase
- PHASE4
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Continuation Study of the Oral AKT Inhibitor GSK2110183
- Status
- COMPLETED
- Phase
- PHASE2